Bojian Fei

2.9k total citations · 1 hit paper
55 papers, 2.1k citations indexed

About

Bojian Fei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bojian Fei has authored 55 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 33 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Bojian Fei's work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (16 papers) and RNA Research and Splicing (11 papers). Bojian Fei is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (16 papers) and RNA Research and Splicing (11 papers). Bojian Fei collaborates with scholars based in China, United States and Japan. Bojian Fei's co-authors include Zhaohui Huang, Zehua Bian, Yuan Yin, Surui Yao, Jiwei Zhang, Leyuan Zhou, Yuyang Feng, Yaling Hu, Xin Jin and Chao Quan and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Scientific Reports.

In The Last Decade

Bojian Fei

52 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages

2022 165 citations Yuan Yin, Bingxin Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bojian Fei China	21	1.5k	1.4k	370	295	170	55	2.1k
Chengwu Zeng China	22	1.6k 1.0×	1.2k 0.8×	323 0.9×	280 0.9×	132 0.8×	60	2.1k
Long Huang China	25	1.2k 0.7×	902 0.7×	296 0.8×	150 0.5×	170 1.0×	72	1.7k
Surui Yao China	19	1.2k 0.8×	964 0.7×	269 0.7×	290 1.0×	114 0.7×	41	1.6k
Chunlin Ou China	26	1.3k 0.9×	897 0.6×	340 0.9×	266 0.9×	127 0.7×	76	1.9k
Cheuk‐Ting Law Hong Kong	17	2.1k 1.4×	1.1k 0.8×	307 0.8×	126 0.4×	144 0.8×	20	2.4k
Chuanyuan Wei China	19	1.1k 0.7×	729 0.5×	343 0.9×	261 0.9×	76 0.4×	52	1.6k
Leyuan Zhou China	15	843 0.5×	762 0.6×	288 0.8×	259 0.9×	104 0.6×	37	1.3k
Lei Deng China	19	1.1k 0.7×	956 0.7×	242 0.7×	240 0.8×	179 1.1×	33	1.5k
Beiqin Yu China	29	2.0k 1.3×	1.6k 1.2×	476 1.3×	182 0.6×	124 0.7×	65	2.7k
Junmin Song China	16	1.3k 0.9×	1.1k 0.8×	191 0.5×	150 0.5×	104 0.6×	40	1.7k

Countries citing papers authored by Bojian Fei

Since Specialization

Citations

This map shows the geographic impact of Bojian Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojian Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojian Fei more than expected).

Fields of papers citing papers by Bojian Fei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojian Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojian Fei. The network helps show where Bojian Fei may publish in the future.

Co-authorship network of co-authors of Bojian Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Bojian Fei. A scholar is included among the top collaborators of Bojian Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojian Fei. Bojian Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Li, et al.. (2024). LINC01094 promotes gastric cancer through dual targeting of CDKN1A by directly binding RBMS2 and HDAC1. Biology Direct. 19(1). 137–137. 2 indexed citations

Wang, Chao, et al.. (2024). Genetic evidence causally linking gastroesophageal reflux disease to cholecystitis: a two-sample mendelian randomization study. BMC Gastroenterology. 24(1). 301–301.

Chen, Yanyan, Meimei Zhang, Surui Yao, et al.. (2024). Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis. Biochemical Pharmacology. 226. 116367–116367.

Chen, Ya, Yanmin Li, Hong Cao, et al.. (2023). Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial. Trials. 24(1). 268–268. 7 indexed citations

Gong, Zhicheng, Yanyan Chen, Meimei Zhang, et al.. (2023). KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations. Clinical Epigenetics. 15(1). 163–163. 13 indexed citations

Tian, Lu, Liang Gong, Yuyang Feng, et al.. (2023). ELOA promotes tumor growth and metastasis by activating RBP1 in gastric cancer. Cancer Medicine. 12(18). 18946–18959. 2 indexed citations

Cui, Kaisa, Liang Gong, Kang Wang, et al.. (2022). Ferroptosis-Associated Molecular Features to Aid Patient Clinical Prognosis and Therapy Across Human Cancers. Frontiers in Immunology. 13. 888757–888757. 4 indexed citations

Qiao, Qiao, et al.. (2022). A Comparison of Endoscopic Closure and Laparoscopic Repair for Gastric Wall Defection. Gastroenterology Research and Practice. 2022. 1–8. 1 indexed citations

Wang, Xue, Han Cheng, Jing Zhao, et al.. (2022). Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. Molecular Cancer. 21(1). 210–210. 36 indexed citations

10.

Feng, Yuyang, Surui Yao, Zhening Pu, et al.. (2021). Identification of New Tumor-Related Gene Mutations in Chinese Gastrointestinal Stromal Tumors. Frontiers in Cell and Developmental Biology. 9. 764275–764275. 4 indexed citations

11.

Cui, Kaisa, Surui Yao, Han Zhang, et al.. (2021). Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer. Oncogene. 40(11). 2130–2145. 22 indexed citations

12.

Bian, Zehua, Jiwei Zhang, Min Li, et al.. (2018). LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clinical Cancer Research. 24(19). 4808–4819. 246 indexed citations

13.

Yin, Yuan, Surui Yao, Yaling Hu, et al.. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. 23(23). 7375–7387. 208 indexed citations

14.

Bian, Zehua, Jiwei Zhang, Min Li, et al.. (2017). Long non-coding RNA LINC00152 promotes cell proliferation, metastasis, and confers 5-FU resistance in colorectal cancer by inhibiting miR-139-5p. Oncogenesis. 6(11). 395–395. 96 indexed citations

15.

Bian, Zehua, Liugen Jin, Jiwei Zhang, et al.. (2016). LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Scientific Reports. 6(1). 23892–23892. 313 indexed citations

16.

Yin, Yuan, Bin-Bin Zhang, Weili Wang, et al.. (2014). miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A. Clinical Cancer Research. 20(23). 6187–6199. 169 indexed citations

17.

Fei, Bojian, L J Alfred, & Yuan Weng. (2013). Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression. World Journal of Surgical Oncology. 11(1). 120–120. 19 indexed citations

18.

Weng, Yuan, Bojian Fei, Ping He, & Ming Cai. (2012). Glutathione-S-Transferase T1 Polymorphism is Associated with Esophageal Cancer Risk in Chinese Han Population. Asian Pacific Journal of Cancer Prevention. 13(9). 4403–4407. 4 indexed citations

19.

Fei, Bojian, Zhaohui Huang, Hua Dong, et al.. (2011). Clinical significance of methylation of plasma Ras-association domain family 1A gene in the molecular diagnosis of hepatocellular carcinoma. Tumori. 31(8). 742–747. 1 indexed citations

20.

Wang, Weili, et al.. (2005). Clinical study on expression of retinoic acid receptors in breast cancer tissues. 25(2). 118–120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact